US drug industry group defends price of Gilead hepatitis drug Reuters India Merck and Bristol-Myers presented new hepatitis C data on Thursday at a major liver disease meeting in London [ID:nL2N0N12E2] [ID:nL2N0N12BT]. Gilead, AbbVie and others will also present clinical trial ... Separately on Thursday, Indian generic ... |
